Metoclopramide vs Placebo for Prevention of Pneumonia in Acute Stroke

Summary

Pneumonia is a major cause of mortality and morbidity in patients with acute stroke fed via nasogastric tubes and may be because of vomiting and gastro-esophageal regurgitation. The aim of the study was to assess whether regular treatment with metoclopramide, a D2-receptor antagonist with antiemetic and gastric prokinetic actions, could reduce the rate of pneumonia.

Timeline

Start

2021-05-02

Primary completion

2021-10-02

Completion

2021-10-02

Drugs

Indications